Top Markets
#1 Black Phoenix Black Phoenix +21,691.70%
#2 Nesa Nesa +775.38%
#3 Cortex Cortex +69.18%
#4 Kinesis Silver Kinesis Silver +55.36%
#5 Pons Pons +25.57%
#6 QuantixAI QuantixAI +23.76%
#7 EXOD EXOD +22.78%
#8 Cash Cat Cash Cat +18.77%
#9 Derive Derive +16.76%
#10 BNB Attestation Service BNB Attestation Service +16.38%
Coin of the day
Black Phoenix Black Phoenix
Settings
Language
ENGLISH
Currency
USD
Theme
Inari Medical, Inc. Inari Medical, Inc.

Inari Medical, Inc.

NARI
Rank in Stocks #3846
Inari Medical, Inc. is a medical technology firm focused on creating,... Inari Medical, Inc. is a medical technology firm focused on creating, producing, promoting, and distributing devices for the minimally invasive management of venous conditions within the United States. Their product portfolio includes ClotTriever, a mechanical thrombectomy solution designed to extract significant clots from major blood vessels, specifically targeting deep vein thrombosis. Another key offering is FlowTriever, a substantial catheter-based aspiration and mechanical thrombectomy system, which addresses pulmonary embolism. The company also provides FlowSaver; FlowStasis, a large-bore suture retention device to manage venous access points; and FlowTriever 2, an enhanced version with a new disk design for efficiently capturing wall-adherent clots and reducing procedure time. Founded in 2011, the company was initially known as Inceptus Newco1 Inc. before rebranding as Inari Medical, Inc. in September 2013. Its corporate headquarters are located in Irvine, California.
Share Price
$79.97
Last synced: 2025-02-19
Market Cap
$4.57B
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
US
Trade Inari Medical, Inc. (NARI)

Category

Healthcare
P/B ratio for Inari Medical, Inc. (NARI)
P/B ratio as of August 2026 TTM: 9.77
According to Inari Medical, Inc. latest financial reports and stock price the company's current price-to-book ratio (TTM) is 9.77. At the end of 2022 the company had a P/B ratio of 8.05.
P/B ratio history for Inari Medical, Inc. from 2018 to 2026
P/B ratio at the end of each year
Year P/B Ratio Change
2026 (TTM) 9.77 23.14%
2023 7.93 -1.57%
2022 8.05 -57.63%
2021 19.01 36.12%
2020 13.96 -126.69%
2019 -52.32 8.01%
2018 -48.45 0.00%
P/B ratio for similar companies or competitors
Company P/B Ratio P/B Ratio Difference Country
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
 3.7944 -61.14%
US
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
 5.423 -44.47%
US
Medtronic plc Medtronic plc
Medtronic plc
MDT.US
 2.0146 -79.37%
IE
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
 3.072 -68.54%
US
Siemens Healthineers AG Siemens Healthineers AG
Siemens Healthineers AG
SHL.DE
 - -
DE